InvestorsHub Logo
Followers 7
Posts 1189
Boards Moderated 0
Alias Born 02/17/2009

Re: BonelessCat post# 54140

Monday, 09/19/2011 3:45:10 PM

Monday, September 19, 2011 3:45:10 PM

Post# of 146240
Apparently, after all contractual fees are paid, Theracour will receive 15% of all revenues as a royalty for its patents. Don't forget that as a major shareholder he will also get his pro-rata share of any dividends paid. I don't expect he's worried about that. If he still controls 30,000,000 plus shares of stock valued at $100/share, who cares about dividends. IMHO EOM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News